Rheumatology Doctors in Belfast, ME Accepting Medicare

3 Rheumatology doctors found. Showing 1 - 3

Kenneth Temple Calamia, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 126 Northport Ave, Suite 106, Belfast, ME 04915 Phone: 207-505-4015

Dr. Akavaram N Reddy, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 116 Northport Ave Ste 220, Belfast, ME 04915 Phone: 207-505-4015    Fax: 207-338-8368

Mary Moran, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 16 Fahey St Ste 202, Belfast, ME 04915 Phone: 207-930-6772    Fax: 207-930-6709

News Archive

Electronic primary care records can help identify untreated patients at high risk of cardiovascular disease

Using routine data from electronic patient records to select individuals at high risk of developing heart disease, rather than screening all adults aged between 40 and 74 years of age, is just as effective at saving lives but will be cheaper to run, according to research published on bmj.com today.

Blood's tendency to clot may contribute to white matter hyperintensities in post-menopausal women

New Mayo Clinic research suggests that blood may hold clues to whether post-menopausal women may be at an increased risk for areas of brain damage that can lead to memory problems and possibly increased risk of stroke. The study shows that blood's tendency to clot may contribute to areas of brain damage called white matter hyperintensities.

COVID-19 pandemic impacts mental, physical health of people with obesity

The COVID-19 pandemic is having a significant impact on people with obesity as they struggle to manage their weight and mental health during shelter-in-place orders, according to research led by The University of Texas Health Science Center at Houston and UT Southwestern.

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

The U.S. Food and Drug Administration today approved a new drug, Arikayce, for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex in a limited population of patients with the disease who do not respond to conventional treatment.

Read more Medical News

› Verified 1 days ago